Collegium to Participate in Upcoming Investor Conferences
08 Novembro 2023 - 10:00AM
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,
diversified specialty pharmaceutical company committed to improving
the lives of people living with serious medical conditions, today
announced that management will participate in the following
investor conferences:
Jefferies 14th Annual
Global Healthcare ConferenceFireside Chat Date and Time:
Tuesday, November 14, 2023, at 9:30 a.m. GMT
Piper Sandler 35th
Annual Healthcare ConferenceFireside Chat Date and
Time: Tuesday, November 28, 2023, at 4:00 p.m. ET
The fireside chat will be webcast live and can be accessed from
the Investors section of the Company's website:
https://ir.collegiumpharma.com. A replay of the webcast will be
archived on the Company's website for 90 days following the
presentation.
About Collegium Pharmaceutical,
Inc.Collegium is a leading, diversified specialty
pharmaceutical company committed to improving the lives of people
living with serious medical conditions. Collegium’s headquarters
are located in Stoughton, Massachusetts. For more information,
please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:Christopher James, M.D.Vice
President, Investor Relationsir@collegiumpharma.com
Media Contact:Marissa SamuelsVice President,
Corporate Communicationscommunications@collegiumpharma.com
Collegium Pharmaceutical (NASDAQ:COLL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024